SCHEMBL37418

SCHEMBL37418

O=[C]C1CCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3967620 1.00
SCHEMBL8357828 1.00
SCHEMBL2707394 0.92
SCHEMBL95320 0.92
SCHEMBL3544913 0.90 ALDH1A1 (0.32)
SCHEMBL3551279 0.90 ALDH1A1 (0.32)
SCHEMBL3547678 0.90 ALDH1A1 (0.32)
SCHEMBL3540638 0.90
SCHEMBL3551062 0.90 ALDH1A1 (0.32)
SCHEMBL3548232 0.90 ALDH1A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2206 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3984994-B1 SUBSTITUTED PIPERIDINE COMPOUND AS OREXIN TYPE 2 AGONIST FOR THE TREATMENT OF NARCOLEPSY TAKEDA PHARMACEUTICALS CO (JP) 2024-07-03 EP claimed
WO-2024114814-A1 JAK INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS ONQUALITY PHARMACEUTICALS CHINA LTD (CN) 2024-06-06 WO claimed
CN-116675685-A Pyridine-containing bisoxazolidone compound and synthetic method and application thereof 东北农业大学 2023-09-01 CN claimed
EP-3896060-B1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2023-08-16 EP claimed
EP-3609883-B1 FLUORINE-SUBSTITUTED INDAZOLE COMPOUNDS AND USES THEREOF SUNSHINE LAKE PHARMA CO LTD (CN) 2022-06-29 EP claimed
EP-3984994-A1 SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2022-04-20 EP claimed
CN-114306324-A Antitumor activity and application of rotigotine and derivatives thereof 万宜合药业(海南)有限责任公司 2022-04-12 CN claimed
CN-114288299-A Antitumor activity and application of LP-211 and derivatives thereof 万宜合药业(海南)有限责任公司 2022-04-08 CN claimed
CN-114246869-A Anti-tumor activity and application of bifeprunox and derivatives thereof 万宜合药业(海南)有限责任公司 2022-03-29 CN claimed
CN-114209701-A Antineoplastic activity and application of vortioxetine and derivative thereof 万宜合药业(海南)有限责任公司 2022-03-22 CN claimed
US-5686612-A ACCELERATORS IN THE MANUFACTURE OF RUBBER AND ACTIVATORS FOR THIAZOLE ACCELERATORS BRANTFORD CHEMICALS INC. (CA) 1997-11-11 US claimed
WO-1997009319-A1 SUBSTITUTED 1-AMINO-3-PHENYLURACIL DERIVATIVES, THEIR PREPARATION AND THEIR USE AS HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 1997-03-13 WO claimed
US-5502035-A N-terminus modified analogs of LHRH TAP HOLDINGS INC. (US) 1996-03-26 US claimed
EP-0656885-A1 SYNTHESIS OF 2-SUBSTITUTED QUINAZOLINE COMPOUNDS (SUCH AS TERAZOSIN) AND MEOBENTINE AND BETHANIDINE AND INTERMEDIATES THEREFOR ACIC (CANADA) INC. (CA) 1995-06-14 EP claimed
US-5312820-A Angiotensin antagonist for treatment of hypertension MERCK & CO., INC. (US) 1994-05-17 US claimed
WO-1994005628-A1 SYNTHESIS OF 2-SUBSTITUTED QUINAZOLINE COMPOUNDS (SUCH AS TERAZOSIN) AND MEOBENTINE AND BETHANIDINE AND INTERMEDIATES THEREFOR ACIC (CANADA) INC. (CA) 1994-03-17 WO claimed
EP-0064255-B1 BENZOPYRANYL ETHERS, PROCESS FOR THEIR PREPARATION AND MEDICINE CONTAINING THOSE COMPOUNDS AND INTERMEDIATES Roche Diagnostics GmbH (DE) 1984-12-12 EP claimed
US-4428955-A ALLERGIC DISEASES BOEHRINGER MANNHEIM GMBH (DE) 1984-01-31 US claimed
EP-0079545-A1 Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same KANEBO, LTD. (JP) 1983-05-25 EP claimed
US-4093726-A HYPOTENSIVE AGENTS ABBOTT LABORATORIES (US) 1978-06-06 US claimed